Microsoft (MSFT) Soars on Qure.ai Partnership to Boost US Lung Cancer AI Tools
Microsoft partners with Qure.ai to expand access to its lung cancer detection and management technology in the U.S., boosting healthcare AI offerings.
Market context
Follow the story. See which markets it affects. Explore the context.
Microsoft partners with Qure.ai to expand access to its lung cancer detection and management technology in the U.S., boosting healthcare AI offerings.
Zacks highlights NVIDIA's AI and quantum partnerships driving healthcare AI adoption, while MedTech names Butterfly Network and Omnicell appear positioned to benefit from rapid market growth.